Answers are grounded in this paper and cite their sources.
The introduction of CTPA was associated with changes consistent with overdiagnosis: rising incidence, minimal change in mortality, and lower case fatality. Better technology allows us to diagnose more emboli, but to minimize harms of overdiagnosis we must learn which ones matter.
No takes yet. Share an insight, caveat, or question.
Wiener et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: